Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Harvard Business School
Dow
Medtronic
AstraZeneca
Johnson and Johnson
Merck

Last Updated: December 15, 2019

DrugPatentWatch Database Preview

Litigation Details for Wyeth v. Mylan Pharmaceuticals Inc. (N.D.W. Va. )

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Small Molecule Drugs cited in Wyeth v. Mylan Pharmaceuticals Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial , and   Start Trial .

Details for Wyeth v. Mylan Pharmaceuticals Inc. (N.D.W. Va. )

Date Filed Document No. Description Snippet Link To Document
2009-05-22 159 These three patents are United States Patent Numbers 6,274,171 B1 (“the ‘171 patent”), 6,403,120 …B1 (“the ‘120 patent”), and 6,419,958 B2 (“the ‘958 patent”) (collectively, the “patents-in-suit”). …three patents-in-suit: claims 20-25 of the ‘171 patent, claims 1, 2, 13 and 14 of the ‘120 patent, and…the ‘171 patent, claims 1, 2, 13, and 14 of the ‘120 patent, and claims 1-6 of the ‘958 patent. …and 23 of the ‘171 patent, 1 of the ‘120 patent, and 1, 3, and 4 of the ‘958 patent. For example External link to document
2009-10-14 230 of its patents, specifically claims 20-25 of U.S. Patent No. 6,274,171 B1 (“the ‘171 patent”), claims…and 14 of U.S. Patent No. 6,403,120 B1 (“the ‘120 patent”), and claims 1-6 of U.S. Patent No. 6,419,9586,419,958 B2 (“the ‘958 patent”) (collectively, the “patents in suit”). These patents are related and …infringe on Wyeth’s patents for that drug. Wyeth also seeks a judgment that its patents are not invalid …court decides that the patent has been infringed, the date that the patent expires; or (iii) External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Express Scripts
Moodys
Merck
AstraZeneca
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.